loadpatents
name:-0.027331113815308
name:-0.010665893554688
name:-0.0089008808135986
Horsley; Helen Tracey Patent Filings

Horsley; Helen Tracey

Patent Applications and Registrations

Patent applications and USPTO patent grants for Horsley; Helen Tracey.The latest application filed is for "fused imidazole derivatives as il-17 modulators".

Company Profile
6.9.13
  • Horsley; Helen Tracey - Slough Berkshire
  • Horsley; Helen Tracey - Slough Berkshire GB
  • Horsley; Helen Tracey - Berkshire UK
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Fused Imidazole Derivatives as IL-17 Modulators
App 20220242855 - Chu; Shuyu ;   et al.
2022-08-04
Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity
App 20210252012 - Brookings; Daniel Christopher ;   et al.
2021-08-19
Therapeutically active pyrazolo-pyrimidine derivatives
Grant RE48,622 - Ford , et al. July 6, 2
2021-07-06
Fused pentacyclic imidazole derivatives as modulators of TNF activity
Grant 10,980,814 - Brookings , et al. April 20, 2
2021-04-20
Fused Imidazole Derivatives as IL-17 Modulators
App 20210053952 - Brace; Gareth Neil ;   et al.
2021-02-25
Fused hexacyclic imidazole derivatives as modulators of TNF activity
Grant 10,766,906 - De Haro Garcia , et al. Sep
2020-09-08
Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity
App 20200046723 - Brookings; Daniel Christopher ;   et al.
2020-02-13
Hexahydropyrazinotriazinone derivatives as kinase inhibitors
Grant 10,450,320 - Horsley , et al. Oc
2019-10-22
Fused Hexacyclic Imidazole Derivatives as Modulators of TNF Activity
App 20190100526 - De Haro Garcia; Teresa ;   et al.
2019-04-04
Hexahydropyrazinotriazinone Derivatives as Kinase Inhibitors
App 20180362532 - Horsley; Helen Tracey ;   et al.
2018-12-20
Fused Pyrazole Derivatives As Kinase Inhibitors
App 20180298009 - Ford; Daniel James ;   et al.
2018-10-18
Fused Pyridine Derivatives As Kinase Inhibitors
App 20180273525 - Horsley; Helen Tracey ;   et al.
2018-09-27
Fused bicyclic heteroaromatic derivatives as kinase inhibitors
Grant 10,000,497 - Horsley , et al. June 19, 2
2018-06-19
Therapeutically active pyrazolo-pyrimidine derivatives
Grant 9,714,248 - Ford , et al. July 25, 2
2017-07-25
Fused Bicyclic Heteroaromatic Derivatives as Kinase Inhibitors
App 20170121337 - Horsley; Helen Tracey ;   et al.
2017-05-04
TNF -.alpha. modulating benzimidazoles
Grant 9,550,737 - Brookings , et al. January 24, 2
2017-01-24
Therapeutically Active Pyrazolo-Pyrimidine Derivatives
App 20160194329 - Ford; Daniel James ;   et al.
2016-07-07
Imidazopyridine derivatives as modulators of TNF activity
Grant 9,309,243 - Bentley , et al. April 12, 2
2016-04-12
Imidazopyridine Derivatives as Modulators of TNF Activity
App 20150203486 - Bentley; Jonathan Mark ;   et al.
2015-07-23
TNF -Alpha Modulating Benzimidazoles
App 20150152065 - Brookings; Daniel Christopher ;   et al.
2015-06-04
Fused thiazole derivatives as kinase inhibitors
Grant 8,242,116 - Alexander , et al. August 14, 2
2012-08-14
Fused Thiazole Derivatives as Kinase Inhibitors
App 20100137302 - Alexander; Rikki Peter ;   et al.
2010-06-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed